Physician

Thomas Charles Sroka, MD

According to 2025 Medicare claims, Thomas Sroka, MD (NPI: 1700058021) practices radiation oncology in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is ONCOLOGY ASSOCIATES OF OREGON P C (NPI: 1013989854; TIN: 930746296) and primary practice location at 97401-6036.

Sroka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 214 traditional Medicare patients, billed 3,133 HCPCS/CPT codes, and received $448,196 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 170 prescription claims across 61 beneficiaries totaling $5,501 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). DME data shows 28 claims. Open Payments data shows 2 records totaling $2,220. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $199,157 to $448,196. Similarly, Part D prescription costs have risen steadily, from $2,796 to $5,501. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$236K$471K2015 Medicare payment: $199,157 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $303,246 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $320,375 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $395,809 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $471,322 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $449,587 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $438,998 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $360,977 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $454,613 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $448,196 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151922,155$199,157
20162123,115$303,246
20172342,338$320,375
20182402,936$395,809
20192523,406$471,322
20202492,768$449,587
20212692,773$438,998
20222372,507$360,977
20232203,422$454,613
20242143,133$448,196

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$89K$178K2015 Drug cost: $2,796 (USD; Tot_Drug_Cst)2016 Drug cost: $2,132 (USD; Tot_Drug_Cst)2017 Drug cost: $2,212 (USD; Tot_Drug_Cst)2018 Drug cost: $3,160 (USD; Tot_Drug_Cst)2019 Drug cost: $5,950 (USD; Tot_Drug_Cst)2020 Drug cost: $4,623 (USD; Tot_Drug_Cst)2021 Drug cost: $4,720 (USD; Tot_Drug_Cst)2022 Drug cost: $178,450 (USD; Tot_Drug_Cst)2023 Drug cost: $8,162 (USD; Tot_Drug_Cst)2024 Drug cost: $5,501 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201528105$2,796
20163384$2,132
20173683$2,212
201844119$3,160
201959214$5,950
202056225$4,623
202151193$4,720
202257180$178,450
202352170$8,162
202461170$5,501

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.0K$4.0K2018 Medicare payment: $3,133 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,460 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,802 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $4,028 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $3,981 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R28$3,133
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R27$1,460
2022N/R34$3,802
2023N/R28$4,028
2024N/R28$3,981

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session57526$293
77427Radiation treatment management, 5 treatment sessions50155$156
77014Ct guidance for insertion of radiation therapy fields61560$98
77336Continuing radiation therapy consultation per week54168$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4971$69

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl673,480$713
Oxycodone HclOxycodone Hcl17177$431
Levothyroxine SodiumLevothyroxine Sodium13390$39

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
B4150Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unitNN/R16$2,878
B4036Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tapeNN/R12$1,103

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.2$2,220AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas Charles Sroka, MD?

Tedicare shows public-source Medicare data for Thomas Charles Sroka, MD (NPI 1700058021), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Charles Sroka, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas Charles Sroka, MD?

Thomas Charles Sroka, MD is linked to ONCOLOGY ASSOCIATES OF OREGON P C (billing NPI 1013989854) in the available physician profile data.

Does Thomas Charles Sroka, MD have Open Payments data?

Thomas Charles Sroka, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.